ArticleJournal of endocrinological investigation2026
Atherogenic index of plasma predicts gestational diabetes mellitus and correlates with disease severity and adverse pregnancy outcomes.
Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly identification of gestational diabetes mellitus (GDM) is essential for timely intervention. The atherogenic index of plasma (AIP) may reflect early lipid dysregulation preceding GDM onset.
methodsThis retrospective cohort included 660 pregnant women who underwent first-trimester (11-13⁺⁶ weeks) lipid testing and GDM screening at 24-28 weeks based on IADPSG criteria. Demographic and biochemical data were extracted from medical records. Logistic regression identified independent predictors of GDM, and receiver operating characteristic (ROC) analysis evaluated predictive performance. Correlation and subgroup analyses examined associations between AIP, glucose parameters, and pregnancy outcomes.
resultsWomen who developed GDM had higher first-trimester AIP levels than those without GDM (0.29 ± 0.17 vs. 0.11 ± 0.11, P < 0.001). AIP independently predicted GDM (OR = 14.37, 95% CI: 3.05-85.35; P < 0.001) and demonstrated higher diagnostic accuracy (AUC = 0.81) compared with TG and HDL-C. Higher AIP correlated with fasting, 1-hour, and 2-hour OGTT glucose levels (all P < 0.001) and was associated with greater risks of prematurity, neonatal asphyxia, and overall adverse outcomes.
conclusionFirst-trimester AIP is a robust biomarker for early prediction of GDM and adverse perinatal outcomes, offering a practical tool for early risk assessment.
Indexed as
Identifiers
41984407What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.